Statistics

Total Visits

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial25

Select a period of time:

Number of views in the range

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial15

Views

Views
May 20240
June 20242
July 20244
August 20244
September 20242
October 20242
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States14
 

Top cities views

Views
Prineville1